Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.67, No.4, p.933–938, 2020 |
||
Title: The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL | ||
Author: M. Kicova, Z Michalova, M. Coma, J. Gabzdilova, K. Dedinska, T. Guman, S. Bernatova, M. Hajikova, M. Giertlova, D. Veselinyova, M. Sarissky | ||
Abstract: CD73 is a membrane-bound enzyme that catalyzes the extracellular conversion of adenosine monophosphate to adenosine. Adenosine is thought to play a role in promoting tumor growth and survival together with suppressing the host immune responses, which contribute to the multistep process of tumorigenesis. Here, we studied the expression of this antigen in chronic lymphocytic leukemia (CLL). The expression of CD73 was analyzed by multiparametric flow cytometry on normal and pathological B-cells from peripheral blood and bone marrow samples from 71 patients with CLL. Pathological B-cells expressed significantly lower levels of CD73 than normal B-cells (p |
||
Keywords: CD73, chronic lymphocytic leukemia, B-cells, flow cytometry, immunophenotyping, overall survival | ||
Published online: 07-Apr-2020 | ||
Year: 2020, Volume: 67, Issue: 4 | Page From: 933, Page To: 938 | |
doi:10.4149/neo_2020_190826N822 |
||
|
download file |
|